Recent advances in intra-articular drug delivery systems to extend drug retention in joint
- 129 Downloads
Intra-articular (IA) administration of therapeutic agents has been employed to selectively deliver active compounds at their site of action for the treatment of chronic joint diseases such as osteoarthritis, rheumatoid arthritis, and joint pain. Direct IA delivery of active compounds to local tissues occasionally provides improved therapeutic outcomes with reduced dose, while minimizing systemic exposure and undesirable adverse effects. However, many small drugs (< 10,000 Da) administered intra-articularly, tend to be rapidly effluxed from the synovium into the blood stream, thus requiring frequent IA injection. To date, different pharmaceutical approaches have been investigated, including polymer and/or lipid-based nanoparticles (NPs), microparticles (MPs), conventional and/or thermo-responsive hydrogels, drug suspension, and oily depot systems, to prolong the drug retention time in the joint, thus improving the pharmacokinetic profile and/or the therapeutic efficacy of active compounds. Herein, we have summarized the recent research trends on IA delivery systems with a focus on NPs, MPs, and hydrogel system, which have been studied most extensively to achieve extended retention time following IA injection.
KeywordsIntra-articular drug delivery Nanoparticles Microparticles Hydrogels Prolonged release Joints
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1C1B1010687).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
- Bodick N, Lufkin J, Willwerth C, Kumar A, Bolognese J, Schoonmaker C, Ballal R, Hunter D, Clayman M (2015) An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial. J Bone Joint Surg Am 97:877–888CrossRefPubMedGoogle Scholar
- Bonanomi MH, Velvart M, Stimpel M, Roos KM, Fehr K, Weder HG (1987) Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis. Rheumatol Int 7:203–212CrossRefPubMedGoogle Scholar
- Brown S, Pistiner J, Adjei I, Sharma B (2017) Nanoparticle properties for delivery to cartilage: the implications of disease state, synovial fluid, and off-target uptake. Mol Pharm. https://doi.org/10.1021/acs.molpharmaceut.7b00484
- Comper WD (1991) Physicochemical aspects of cartilage extracellular matrix. In: Hall B, Newman S (eds) Cartilage: molecular aspects. CRC Press, Boston, pp 59–96Google Scholar
- Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K, Araujo AB (2017) Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014. Rheumatol Int 37:1551–1557Google Scholar
- Kim SR, Ho MJ, Lee E, Lee JW, Choi YW, Kang MJ (2015) Cationic PLGA/Eudragit RL nanoparticles for increasing retention time in synovial cavity after intra-articular injection in knee joint. Int J Nanomed 10:5263–5271Google Scholar
- Kraus VB, Conaghan PG, Aazami HA, Mehra P, Kivitz AJ, Lufkin J, Hauben J, Johnson JR, Bodick N (2017) Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis. Osteoarthr Cartil 26:34–42Google Scholar
- Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26–35CrossRefPubMedPubMedCentralGoogle Scholar
- Martini FH (2006) Fundamentals of anatomy and physiology: international edition (7th edn). Pearson Education, Inc., New YorkGoogle Scholar
- Matsuzaki T, Matsushita T, Tabata Y, Saito T, Matsumoto T, Nagai K, Kuroda R, Kurosaka M (2014) Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. Biomaterials 35:9904–9911CrossRefPubMedGoogle Scholar
- Petit A, Sandker M, Müller B, Meyboom R, van Midwoud P, Bruin P, Redout EM, Versluijs-Helder M, van der Lest CH, Buwalda SJ, de Leede LG, Vermonden T, Kok RJ, Weinans H, Hennink WE (2014) Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA–PEG–PCLA thermogels. Biomaterials 35:7919–7928CrossRefPubMedGoogle Scholar
- Petit A, Redout EM, van de Lest CH, de Grauw JC, Müller B, Meyboom R, van Midwoud P, Vermonden T, Hennink WE, René van Weeren P (2015) Sustained intra-articular release of celecoxib from in situ forming gels made of acetyl-capped PCLA–PEG–PCLA triblock copolymers in horses. Biomaterials 53:426–436CrossRefPubMedGoogle Scholar